PKD1 and cyst: However, renal Pparg expression only starts after E14.552, suggesting that either extra-renal effects (i.e. on the correction of cardiac defects and/or on subcutaneous oedema) or other pioglitazone targets explain the cyst inhibiting effects in the Pkd1−/− embryos.